BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 17240241)

  • 1. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction.
    Bahtiyar MO; Buhimschi C; Ravishankar V; Copel J; Norwitz E; Julien S; Guller S; Buhimschi IA
    Am J Obstet Gynecol; 2007 Jan; 196(1):72.e1-6. PubMed ID: 17240241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal nucleated red blood cells in a rat model of intrauterine growth restriction induced by hypoxia and nitric oxide synthase inhibition.
    Ravishankar V; Buhimschi CS; Booth CJ; Bhandari V; Norwitz E; Copel J; Buhimschi IA
    Am J Obstet Gynecol; 2007 May; 196(5):482.e1-8. PubMed ID: 17466713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study.
    Bergen NE; Bouwland-Both MI; Steegers-Theunissen RP; Hofman A; Russcher H; Lindemans J; Jaddoe VW; Steegers EA
    Hum Reprod; 2015 Jun; 30(6):1302-13. PubMed ID: 25854264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
    Xiang QQ; Yang Z; Huai J; Wang GJ
    Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):601-607. PubMed ID: 31550776
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of soluble vascular endothelial growth factor receptor-1 and placental growth factor in fetal growth restriction cases and intervention effect of tetramethylpyrazine.
    Li SW; Ling Y; Jin S; Lin YF; Chen ZJ; Hu CX; Wang MH; Yao MZ
    Asian Pac J Trop Med; 2014 Aug; 7(8):663-667. PubMed ID: 25149383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.
    Wallner W; Sengenberger R; Strick R; Strissel PL; Meurer B; Beckmann MW; Schlembach D
    Clin Sci (Lond); 2007 Jan; 112(1):51-7. PubMed ID: 16928195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating angiogenic factors and placental abruption.
    Signore C; Mills JL; Qian C; Yu K; Lam C; Epstein FH; Karumanchi SA; Levine RJ
    Obstet Gynecol; 2006 Aug; 108(2):338-44. PubMed ID: 16880304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
    Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
    Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies.
    Buhimschi IA; Shi SQ; Saade GR; Garfield RE
    Am J Obstet Gynecol; 2001 Mar; 184(4):686-93. PubMed ID: 11262473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
    Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
    J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction.
    Shinohara S; Uchida Y; Kasai M; Sunami R
    Hypertens Pregnancy; 2017 Aug; 36(3):269-275. PubMed ID: 28737473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoring placental growth factor-soluble fms-like tyrosine kinase-1 balance reverses vascular hyper-reactivity and hypertension in pregnancy.
    Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
    Am J Physiol Regul Integr Comp Physiol; 2016 Sep; 311(3):R505-21. PubMed ID: 27280428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
    Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
    Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats.
    Thaete LG; Neerhof MG; Silver RK
    J Soc Gynecol Investig; 2001; 8(1):18-23. PubMed ID: 11223352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
    Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
    Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating angiogenic factors and their association with birth outcomes in preeclampsia.
    Kulkarni AV; Mehendale SS; Yadav HR; Kilari AS; Taralekar VS; Joshi SR
    Hypertens Res; 2010 Jun; 33(6):561-7. PubMed ID: 20224572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
    Ren Z; Cui N; Zhu M; Khalil RA
    Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of maternal serum angiogenic factors in third-trimester normal pregnancies: reference ranges, influence of maternal and pregnancy factors and fetoplacental Doppler indices.
    Lobmaier SM; Figueras F; Mercade I; Crovetto F; Peguero A; Parra-Saavedra M; Ortiz JU; Crispi F; Gratacós E
    Fetal Diagn Ther; 2014; 36(1):38-43. PubMed ID: 24903330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium hydrosulfide prevents hypertension and increases in vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in hypertensive pregnant rats.
    Possomato-Vieira JS; Gonçalves-Rizzi VH; Graça TU; Nascimento RA; Dias-Junior CA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1325-1332. PubMed ID: 27620880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.